Novartis Misses Estimates as Vaccine Unit Slumps

Novartis Misses Estimates as Vaccine Unit Slumps Play

July 17 (Bloomberg) -- Novartis AG, the world’s largest drugmaker by revenue, reported second-quarter profit that missed analysts’ estimates, dragged down by declining sales and a worsening loss in the vaccine division it’s selling. Helvea Analyst Odile Rundquist speaks on “The Pulse.” (Source: Bloomberg)

  • On Air Now

    PAID PROGRAMMING Watch Now

  • Next

    PAID PROGRAMMING

blog comments powered by Disqus